Yousif Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
FWIA
RRAM
PCM
CF
AWM
AB
Yousif Capital Management's BMRN Position: Q2 2026 in Review
Yousif Capital Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 5.4% in Q2 2026, selling an estimated $174K and leaving 55,287 shares worth $3.16M. The position accounts for 0.04% of the portfolio, ranked #471.
Yousif Capital Management first reported a position in BMRN in Q4 2021 and has held it in 15 quarters since. The position peaked at $6.76M in Q2 2024. 91 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- Yousif Capital Management held 55,287 shares of BioMarin Pharmaceuticals worth $3.16M as of Q2 2026.
- Yousif Capital Management sold 3,172 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $174K.
- BioMarin Pharmaceuticals made up 0.04% of Yousif Capital Management's portfolio in Q2 2026, its #471 holding.
- Yousif Capital Management first reported a position in BioMarin Pharmaceuticals in Q4 2021 and has held it in 15 quarters since.
- Yousif Capital Management's BioMarin Pharmaceuticals position peaked at $6.76M in Q2 2024.
- 91 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.